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*Staphylococcus aureus* is an opportunistic pathogen that can cause food poisoning, as well as a variety of infections ([@B1]). *Staphylococcus aureus* subsp. *aureus* ATCC 25923 is a clinical isolate with the designation Seattle 1945 that is used as a standard laboratory testing control strain. It is sensitive to a variety of antibiotics, including methicillin. The isolate contains a staphylococcal cassette chromosome--like (SCC-like) element that lacks both recombinases and *mecA* ([@B2], [@B3]). We report the complete genome of the isolate, comprising a 2,778,854-bp chromosome and a 27,491-bp plasmid, pS1945.

Genomic DNA was prepared from an isolate purchased through Remel Inc. (Lenexa, KS) under license with American Type Culture Collection (ATCC), and a 10-kb insert library was sequenced on the Pacific Biosciences RSII system*. De novo* assembly with Celera Assembler version 8.1 ([@B4]) and polishing with Quiver version 0.8 ([@B5]) resulted in a single contig each for the chromosome and plasmid. The average coverage for the chromosomal contig was 408×, and average coverage for the plasmid contig was 593×.

To our knowledge, this is the first report of a native plasmid in the ATCC 25923 (Seattle 1945) strain. The plasmid was nearly identical to plasmid SAP019A from the *S. aureus* strain NRS104 (GenBank accession GQ900385), containing two small insertions relative to SAP019A.
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--------------------------------------

The complete genome sequences of the chromosome and plasmid have been deposited in DDBJ/ENA/GenBank under the accession numbers [CP009361](CP009361) and [CP009362](CP009362), respectively.
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